BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19901711)

  • 1. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage.
    Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H
    Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep venous thrombosis prophylaxis in cerebral hemorrhage.
    Zubkov AY; Wijdicks EF
    Rev Neurol Dis; 2009; 6(1):21-5. PubMed ID: 19367220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage.
    Wasay M; Khan S; Zaki KS; Khealani BA; Kamal A; Azam I; Khatri IA
    J Pak Med Assoc; 2008 Jul; 58(7):362-4. PubMed ID: 18988406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin for deep vein thrombosis in glioma patients.
    Schmidt F; Faul C; Dichgans J; Weller M
    J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.
    Lacut K; Bressollette L; Le Gal G; Etienne E; De Tinteniac A; Renault A; Rouhart F; Besson G; Garcia JF; Mottier D; Oger E;
    Neurology; 2005 Sep; 65(6):865-9. PubMed ID: 16186525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.
    Kiphuth IC; Staykov D; Köhrmann M; Struffert T; Richter G; Bardutzky J; Kollmar R; Mäurer M; Schellinger PD; Hilz MJ; Doerfler A; Schwab S; Huttner HB
    Cerebrovasc Dis; 2009; 27(2):146-50. PubMed ID: 19039218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
    Wein L; Wein S; Haas SJ; Shaw J; Krum H
    Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboembolic prophylaxis after major abdominal surgery].
    Celebi F; Balik AA; Yildirgan MI; Başoğlu M; Adigüzel H; Oren D
    Ulus Travma Derg; 2001 Jan; 7(1):44-8. PubMed ID: 11705173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin.
    Kurtoglu M; Yanar H; Bilsel Y; Guloglu R; Kizilirmak S; Buyukkurt D; Granit V
    World J Surg; 2004 Aug; 28(8):807-11. PubMed ID: 15457363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.